12-Nov-2018
Don’t trade our lives away
Civil society organisations, patient groups and health activists have been concerned about intellectual property provisions being discussed in RCEP which undermine access to medicines and affordable treatment for patients
8-Nov-2018
The Guardian.pe.ca
Canada’s negotiators extended data protection on biologics without knowing impact on prices.
9-Oct-2018
European Pharmaceutical Manufacturer
Patients may need to wait an extra five or 10 years to access generic medicines, which could raise healthcare costs by as $100 billion over the next five years, according to the latest CPhI annual report
5-Oct-2018
Financial Post
Experts are fuming, saying USMCA will hamper Canada’s innovation economy and hike costs to the health care system over patented drugs.
2-Oct-2018
Knowledge Ecology International
The damages provisions in the new trade agreement are dangerous, and create a norm that is in conflict with national laws.
5-Sep-2018
Financial Express
New Delhi won’t not take additional commitment on intellectual property rights beyond the TRIPS agreement it has already accepted at the WTO; investor-state dispute settlement (ISDS) mechanism only for limited sectors.
13-Jun-2018
The Japan Times
Japan’s bicameral legislature, The Diet has approved a bill on to ratify the 11-country Comprehensive and Progressive Agreement for Trans-Pacific Partnership.